Platinum Industries enters life sciences sector with focus on APIs and intermediates

Mumbai-based Platinum Industries, an innovation-driven specialty chemicals company, has announced its strategic entry into the life sciences sector, marking a significant step in its next phase of growth. As part of this expansion, the company has appointed Dr Abhigyan Upadhyay to lead its new life sciences enterprise.

This move reflects Platinum Industries’ continued evolution from delivering advanced chemistry solutions to enabling applications that directly impact human health, an extension of its broader philosophy of translating chemistry into care through innovation, quality, and responsibility. The company aims to build a disciplined, research-driven, and globally scalable presence in high-value life sciences segments. 

Dr Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments. In his previous roles, he has led large-scale businesses and driven transformation and market expansion across international markets in life sciences. He has also contributed immensely during the COVID-19 pandemic leveraging his critical life sciences capabilities by being involved in various clinical trials and research initiatives.

Platinum Industries is set to foray into the life sciences sector through its wholly owned subsidiary, Rivadu Lifesciences. The company will adopt a phased, innovation-led approach to building its life sciences business, with an initial focus on research-driven segments such as APIs and intermediates, working closely with partners and leveraging its strengths in execution and market access to build a scalable model with a strong presence not just in India, but across key international markets, including the Middle East, the United States, Europe, and Asia.